Huw Jones

Huw has over 30 years’ experience of leadership roles in public and private R&D-based companies within the biotechnology and pharmaceutical sector, with a particular focus on preclinical and clinical drug development, dilutive and non-dilutive financing and business development. He is Chairman of Chronos Therapeutics Ltd, Non-executive Director of IxaKa Ltd (formerly Rexgenero) and a member of the board of Biotech industry body OBN. Huw holds a PhD in pharmacology from the University of Birmingham, UK.